Previous Page  11 / 20 Next Page
Information
Show Menu
Previous Page 11 / 20 Next Page
Page Background

Page 41

Notes:

allied

academies

March 07-08, 2019 | London, UK

Journal of Diabetology | Volume 3

Annual Summit on

Diabetes, Obesity & Heart

Diabetes, Endocrinology and Metabolic Syndrome

International Conference on

Joint Event

&

Impact of Roux-en-Y gastric bypass on metabolomic profile of obese women with type 2 diabetes

Natasha Machado

University of Sao Paulo, Brazil

T

ype 2 diabetes (T2D) remission rates reach up to 60% after

Roux-en-Y gastric bypass (RYGB) in obese patients, but the

precise mechanisms are not fully understood. We developed

a prospective clinical study to investigate the molecular basis

of these metabolic alterations through metabolomics. Plasma

and urine samples were collected from 23 obese women with

T2D before and after 3months of RYGB. Subjects were analysed

together and divided according T2D remission. Metabolomic

profile exhibited a discriminatory pattern of alterations,

suggesting important differences between patients with and

without T2D remission. The main metabolites involved in

these alterations includes bile acids, uremic toxins produced by

microbiota, dicarboxylic acids, and different lipid classes. The

contrast of the metabolite alterations allowed us to suggest

several hypotheses. T2D remission could be associated with

metabolic flexibility improvement, stimulated by increased

oxidation and nuclear receptors activation, modifying lipid

and glucose metabolism. In contrast, non-remission of T2D

in obese patients after RYGB could be related to a subclinical

kidney dysfunction. This was hypothesized considering that

metabolic alterations observed on T2D remission rely on kidney

function and its local enzymes and metabolite alterations of

patients who do not present T2D remission could be associated

to kidney disturbances. Thus, we suggest that RYGB deeply

changes metabolomic profile and develop a functional role,

including – but not limited to – regulation in the substrate

flux and utilization, microbiota composition or activity and

activation of nuclear receptors. These metabolic alterations

seem to act together to forma circuit of alterations that activate

triggers that lead to T2D improvement, which deserves future

investigations.

e:

natashamachado@gmail.com